0001567619-20-008617.txt : 20200429
0001567619-20-008617.hdr.sgml : 20200429
20200429184933
ACCESSION NUMBER: 0001567619-20-008617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200427
FILED AS OF DATE: 20200429
DATE AS OF CHANGE: 20200429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilbert Halley E
CENTRAL INDEX KEY: 0001601360
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 20832297
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2020-04-27
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001601360
Gilbert Halley E
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BLVD., STE. 400
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
9.25
2020-04-27
4
A
0
40000
0.00
A
2030-04-26
Common Stock
40000
40000
D
1/36th of the shares subject to the option vest on each monthly anniversary measured from April 27, 2020 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
/s/ Lloyd Rowland, as Attorney-in-Fact for Halley E. Gilbert
2020-04-29